ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hepatic CPT1A Facilitates Liver Adipose Cross Talk via Induction of FGF21 in Mice

Sun, Wei; Nie, Tao; Li, Kuai; Wu, Wenjie; Long, Qiaoyun; Feng, Tianshi; Mao, Liufeng; Gao, Yuan; Liu, Qing; Gao, Xuefei; Ye, Dewei; Yan, Kaixuan; Gu, Ping; Xu, Yong; Zhao, Xuemei; Chen, Kang; Loomes, Kerry Martin; Lin, Shaoqiang*; Wu, Donghai*; Hui, Xiaoyan*广东药学院; 广州医学院; 南方医科大学; 南京大学; 中国科学院; 1
Diabetes2022-1DOI: 10.2337/db21-0363
23被引9阅读
引用收藏
分享

摘要

Hepatosteatosis, defined as excessive intrahepatic lipid accumulation, represents the first step of nonalcoholic fatty liver disease (NAFLD). When combined with additional cellular stress, this benign status progresses to local and systemic pathological conditions such as nonalcoholic steatohepatitis and insulin resistance. However, the molecular events directly caused by hepatic lipid buildup, in terms of its impact on liver biology and peripheral organs, remain unclear. Carnitine palmitoyltransferase 1A (CPT1A) is the rate-limiting enzyme for long-chain fatty acid beta-oxidation in the liver. In this study, we use hepatocyte-specific Cptla knockout (LKO) mice to investigate the physiological consequences of abolishing hepatic long-chain fatty acid metabolism. Compared with the wild-type littermates, high-fat diet (HFD)-fed LKO mice displayed more severe hepatosteatosis but were otherwise protected against diet-induced weight gain, insulin resistance, hepatic endoplasmic reticulum stress, inflammation, and damage. Interestingly, increased energy expenditure was observed in LKO mice, accompanied by enhanced adipose tissue browning. RNA-sequencing analysis revealed that the peroxisome proliferator-activated receptor alpha-fibroblast growth factor 21 (FGF21) axis was activated in liver of LKO mice. Importantly, antibody- mediated neutralization of FGF21 abolished the healthier metabolic phenotype and adipose browning in LKO mice, indicating that the elevation of FGF21 contributes to the improved liver pathology and adipose browning in HFD-treated LKO mice. Liver with deficient CPT1A expression adopts a healthy steatotic status that protects against HFD-evoked liver damage and potentiates adipose browning in an FGF21-dependent manner. Inhibition of hepatic CPT1A may serve as a viable strategy for the treatment of obesity and NAFLD.

学科与关键词

关键词
GROWTH-FACTOR 21ENDOPLASMIC-RETICULUM STRESSINSULIN-RESISTANCEPPAR-ALPHAINHIBITIONGLUCOSEEXPRESSIONTISSUEGLUCONEOGENESISDEFICIENCY
相关
加载中…
  • Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1α
    Xu, Lu; Huang, Zhe; Lo, Tak-ho; Lee, Jimmy Tsz Hang; Yang, Ranyao; Yan, Xingqun; Ye, Dewei; Xu, Aimin*; Wong, Chi-Ming*2022, 12(6): 2502-2518.被引 8
  • Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR
    Guo, Jingyi; Huang, Shangyi; Yi, Qincheng; Liu, Naihua; Cui, Tianqi; Duan, Siwei; Chen, Jiabing; Li, Jiayu; Li, Jun; Wang, Lei*; Gao, Yong*; Nie, Guangning*ACS OMEGA, 2023, 8(29): 26158-26169.
  • Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice
    Yuan, Youwen; Li, Kangli; Teng, Fei; Wang, Weiwei; Zhou, Bing; Zhou, Xuan; Lin, Jiayang; Ye, Xueru; Deng, Yajuan; Liu, Wenhui; Luo, Shenjian; Zhang, Peizhen; Liu, Deying; Zheng, Minghua; Li, Jin; Lu, Yan*; Zhang, Huijie*Journal of Biological Chemistry, 2022, 298(6): 101946.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Diabetes
发表日期
2022-01
卷期
第 71 卷, 第 1 期
页码
31-42
DOI
10.2337/db21-0363
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
Frontier Research Program of Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory) [2018GZR110105019]; Guangzhou International Collaborative Grant [2019A050510027]; International Partnership Program of the Chinese Academy of Sciences [154144KYSB20180063]; National Natural Science Foundation of China Excellent Young Scientists Fund (Hong Kong and Macau) [81922079]; National Natural Science Foundation of China [81970729, 81670800, 81774134]; Science and Technology Planning Project of Guangdong Province, China [2020B1212060052]; Guangdong Provincial Public Interest Research and Capacity Building Projects [2014A010107024]; Natural Science Foundation of Jiangsu Province of China [BK20171331]

作者

  • S

    Sun, Wei (第一作者)

    1 · guangdong pharmaceut univ · chinese acad sci · guangzhou inst biomed & hlth · guangzhou med univ

  • N

    Nie, Tao

    chinese acad sci · guangzhou inst biomed & hlth · chinese univ hong kong · guangzhou med univ

查看全部 20 位作者收起作者
  • L

    Li, Kuai

    chinese acad sci · chinese univ hong kong · guangzhou inst biomed & hlth · guangzhou med univ

  • W

    Wu, Wenjie

    chinese univ hong kong

  • L

    Long, Qiaoyun

    chinese univ hong kong

  • F

    Feng, Tianshi

    univ hong kong

  • M

    Mao, Liufeng

    1 · guangdong pharmaceut univ

  • G

    Gao, Yuan

    univ hong kong

  • L

    Liu, Qing

    univ hong kong

  • G

    Gao, Xuefei

    southern med univ

  • Y

    Ye, Dewei

    guangdong pharmaceut univ

  • Y

    Yan, Kaixuan

    guangdong pharmaceut univ

  • G

    Gu, Ping

    nanjing univ

  • X

    Xu, Yong

    chinese acad sci · guangzhou inst biomed & hlth · guangzhou med univ

  • Z

    Zhao, Xuemei

    chinese univ hong kong

  • C

    Chen, Kang

    univ hong kong

  • L

    Loomes, Kerry Martin

    new

  • L

    Lin, Shaoqiang (通讯)

    1 · guangdong pharmaceut univ

  • W

    Wu, Donghai (通讯)

    guangzhou med univ · chinese acad sci · chinese univ hong kong · guangzhou inst biomed & hlth

  • H

    Hui, Xiaoyan (通讯)

    chinese univ hong kong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417